The anti-retropulsion devices market size has grown strongly in recent years. It will grow from $2.56 billion in 2025 to $2.75 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising incidence of kidney stones and urolithiasis, increasing adoption of ureteroscopy and lithotripsy procedures, early availability of basket and balloon anti-retropulsion devices, growth in hospital-based urology surgery volumes, increasing focus on stone clearance efficiency.
The anti-retropulsion devices market size is expected to see strong growth in the next few years. It will grow to $3.51 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for minimally invasive stone removal technologies, increasing use of disposable anti-retropulsion devices, growth in ambulatory stone treatment procedures, expanding development of specialized device designs for complex stones, increasing investments in urology care infrastructure. Major trends in the forecast period include rising preference for advanced anti-retropulsion devices to improve stone stabilization during lithotripsy, increasing utilization of basket and balloon-type devices to minimize proximal stone migration, growing clinical shift toward minimally invasive ureteroscopy-based stone management, expanding adoption of procedure-specific device designs for complex ureteral anatomies, increasing demand for disposable and single-use anti-retropulsion devices to reduce infection risk.
The increasing prevalence of chronic kidney disease is anticipated to drive the growth of the anti-retropulsion device market in the coming years. Chronic kidney disease encompasses a wide range of conditions that impair the structure and function of the kidneys. Factors such as poor dietary habits, sedentary lifestyles, obesity, smoking, and excessive alcohol consumption significantly contribute to the rising burden of renal disorders. Anti-retropulsion devices are employed to improve the effectiveness of urological procedures by preventing kidney stone fragments from migrating back toward the kidney during treatment. For example, in May 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, the prevalence of chronic kidney disease among adults in the United States was estimated at more than 14%, affecting approximately 35.5 million individuals, up from 13% in 2023. As a result, the growing prevalence of chronic kidney disease is expected to fuel the expansion of the anti-retropulsion device market.
Companies operating in the anti-retropulsion device market are emphasizing design enhancements and user-focused innovations, such as vacuum-assisted kidney stone removal devices, to improve clinical outcomes and reduce procedure durations. Vacuum-assisted kidney stone removal devices are medical instruments designed to increase the efficiency of urological procedures by using suction to capture and extract kidney stones from the urinary tract. For instance, in March 2024, Calyxo, Inc., a US-based medical device company focused on advancing care for patients with kidney stones, introduced the CVAC System. This comprehensive solution is designed for efficient and effective kidney stone removal by combining irrigation and vacuum aspiration to continuously clear stone fragments during and after laser lithotripsy, enabling physicians to achieve stone-free results.
In June 2024, The Medical City, a Philippines-based hospital, acquired the Lumenis Moses 2 machine for an undisclosed amount. The acquisition is intended to enhance The Medical City’s urological service offerings by enabling advanced, minimally invasive treatment options for kidney stones and benign prostatic hyperplasia. It aims to improve patient outcomes through greater procedural precision, improved efficiency, and shorter recovery times. Lumenis Ltd. is an Israel-based company specializing in the development of anti-retropulsion devices.
Major companies operating in the anti-retropulsion devices market are Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Cook Medical Incorporated, KARL STORZ SE & Co KG, Coloplast A/S, ROCAMED SAM, Endotherapeutics Pty Ltd, Dornier MedTech GmbH, Accordion Medical LLC, Cogentix Medical Inc., NeoScope Inc, OTU Medical, Clarion Medical Technologies, Calyxo Inc, EMS Urology, Happiness Works Medical, PENTAX Medical, UROMED Kurt Drews KG, EndoTheia Inc, Maxer Endoscopy GmbH.
North America was the largest region in the anti-retropulsion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-retropulsion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anti-retropulsion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the anti-retropulsion devices market by increasing import costs for nitinol baskets, balloon catheters, polymer components, and precision wire systems sourced through global supply chains, leading to higher procurement costs for hospitals and ambulatory surgical centers. The effect is more significant in Asia-Pacific, Latin America, and Middle Eastern regions that rely heavily on imported basket-type and balloon-type devices used in ureteroscopy and lithotripsy procedures. However, tariffs are also encouraging localized manufacturing, regional assembly, and supplier diversification, which can strengthen domestic device production and enhance long-term supply stability across key product segments.
The anti-retropulsion devices market research report is one of a series of new reports that provides anti-retropulsion devices market statistics, including anti-retropulsion devices industry global market size, regional shares, competitors with a anti-retropulsion devices market share, detailed anti-retropulsion devices market segments, market trends and opportunities, and any further data you may need to thrive in the anti-retropulsion devices industry. This anti-retropulsion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Anti-retropulsion devices are instruments utilized in medical procedures, particularly in urology, to prevent kidney stones or fragments from moving back up the ureter towards the kidney during lithotripsy or other stone removal procedures. These tools stabilize stones or fragments within the urinary tract, aiding their passage or extraction without causing obstruction or complications.
The primary types of anti-retropulsion devices include basket-type, balloon-type, and other specialized variants. Basket-type devices are specifically designed for urological procedures to capture and remove kidney stones or fragments. These devices find applications in ureteroscopy, lithotripsy, and are used in settings such as hospitals and ambulatory surgical centers.
The anti-retropulsion devices market consists of sales of retrieval baskets, ureteral access sheaths, and tipless nitinol stone baskets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The anti-retropulsion devices market size is expected to see strong growth in the next few years. It will grow to $3.51 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for minimally invasive stone removal technologies, increasing use of disposable anti-retropulsion devices, growth in ambulatory stone treatment procedures, expanding development of specialized device designs for complex stones, increasing investments in urology care infrastructure. Major trends in the forecast period include rising preference for advanced anti-retropulsion devices to improve stone stabilization during lithotripsy, increasing utilization of basket and balloon-type devices to minimize proximal stone migration, growing clinical shift toward minimally invasive ureteroscopy-based stone management, expanding adoption of procedure-specific device designs for complex ureteral anatomies, increasing demand for disposable and single-use anti-retropulsion devices to reduce infection risk.
The increasing prevalence of chronic kidney disease is anticipated to drive the growth of the anti-retropulsion device market in the coming years. Chronic kidney disease encompasses a wide range of conditions that impair the structure and function of the kidneys. Factors such as poor dietary habits, sedentary lifestyles, obesity, smoking, and excessive alcohol consumption significantly contribute to the rising burden of renal disorders. Anti-retropulsion devices are employed to improve the effectiveness of urological procedures by preventing kidney stone fragments from migrating back toward the kidney during treatment. For example, in May 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, the prevalence of chronic kidney disease among adults in the United States was estimated at more than 14%, affecting approximately 35.5 million individuals, up from 13% in 2023. As a result, the growing prevalence of chronic kidney disease is expected to fuel the expansion of the anti-retropulsion device market.
Companies operating in the anti-retropulsion device market are emphasizing design enhancements and user-focused innovations, such as vacuum-assisted kidney stone removal devices, to improve clinical outcomes and reduce procedure durations. Vacuum-assisted kidney stone removal devices are medical instruments designed to increase the efficiency of urological procedures by using suction to capture and extract kidney stones from the urinary tract. For instance, in March 2024, Calyxo, Inc., a US-based medical device company focused on advancing care for patients with kidney stones, introduced the CVAC System. This comprehensive solution is designed for efficient and effective kidney stone removal by combining irrigation and vacuum aspiration to continuously clear stone fragments during and after laser lithotripsy, enabling physicians to achieve stone-free results.
In June 2024, The Medical City, a Philippines-based hospital, acquired the Lumenis Moses 2 machine for an undisclosed amount. The acquisition is intended to enhance The Medical City’s urological service offerings by enabling advanced, minimally invasive treatment options for kidney stones and benign prostatic hyperplasia. It aims to improve patient outcomes through greater procedural precision, improved efficiency, and shorter recovery times. Lumenis Ltd. is an Israel-based company specializing in the development of anti-retropulsion devices.
Major companies operating in the anti-retropulsion devices market are Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Cook Medical Incorporated, KARL STORZ SE & Co KG, Coloplast A/S, ROCAMED SAM, Endotherapeutics Pty Ltd, Dornier MedTech GmbH, Accordion Medical LLC, Cogentix Medical Inc., NeoScope Inc, OTU Medical, Clarion Medical Technologies, Calyxo Inc, EMS Urology, Happiness Works Medical, PENTAX Medical, UROMED Kurt Drews KG, EndoTheia Inc, Maxer Endoscopy GmbH.
North America was the largest region in the anti-retropulsion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-retropulsion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anti-retropulsion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the anti-retropulsion devices market by increasing import costs for nitinol baskets, balloon catheters, polymer components, and precision wire systems sourced through global supply chains, leading to higher procurement costs for hospitals and ambulatory surgical centers. The effect is more significant in Asia-Pacific, Latin America, and Middle Eastern regions that rely heavily on imported basket-type and balloon-type devices used in ureteroscopy and lithotripsy procedures. However, tariffs are also encouraging localized manufacturing, regional assembly, and supplier diversification, which can strengthen domestic device production and enhance long-term supply stability across key product segments.
The anti-retropulsion devices market research report is one of a series of new reports that provides anti-retropulsion devices market statistics, including anti-retropulsion devices industry global market size, regional shares, competitors with a anti-retropulsion devices market share, detailed anti-retropulsion devices market segments, market trends and opportunities, and any further data you may need to thrive in the anti-retropulsion devices industry. This anti-retropulsion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Anti-retropulsion devices are instruments utilized in medical procedures, particularly in urology, to prevent kidney stones or fragments from moving back up the ureter towards the kidney during lithotripsy or other stone removal procedures. These tools stabilize stones or fragments within the urinary tract, aiding their passage or extraction without causing obstruction or complications.
The primary types of anti-retropulsion devices include basket-type, balloon-type, and other specialized variants. Basket-type devices are specifically designed for urological procedures to capture and remove kidney stones or fragments. These devices find applications in ureteroscopy, lithotripsy, and are used in settings such as hospitals and ambulatory surgical centers.
The anti-retropulsion devices market consists of sales of retrieval baskets, ureteral access sheaths, and tipless nitinol stone baskets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Anti-Retropulsion Devices Market Characteristics
3. Anti-Retropulsion Devices Market Supply Chain Analysis
4. Global Anti-Retropulsion Devices Market Trends and Strategies
5. Anti-Retropulsion Devices Market Analysis of End Use Industries
7. Global Anti-Retropulsion Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Anti-Retropulsion Devices Total Addressable Market (TAM) Analysis for the Market
9. Anti-Retropulsion Devices Market Segmentation
10. Anti-Retropulsion Devices Market Regional and Country Analysis
11. Asia-Pacific Anti-Retropulsion Devices Market
12. China Anti-Retropulsion Devices Market
13. India Anti-Retropulsion Devices Market
14. Japan Anti-Retropulsion Devices Market
15. Australia Anti-Retropulsion Devices Market
16. Indonesia Anti-Retropulsion Devices Market
17. South Korea Anti-Retropulsion Devices Market
18. Taiwan Anti-Retropulsion Devices Market
19. South East Asia Anti-Retropulsion Devices Market
20. Western Europe Anti-Retropulsion Devices Market
21. UK Anti-Retropulsion Devices Market
22. Germany Anti-Retropulsion Devices Market
23. France Anti-Retropulsion Devices Market
24. Italy Anti-Retropulsion Devices Market
25. Spain Anti-Retropulsion Devices Market
26. Eastern Europe Anti-Retropulsion Devices Market
27. Russia Anti-Retropulsion Devices Market
28. North America Anti-Retropulsion Devices Market
29. USA Anti-Retropulsion Devices Market
30. Canada Anti-Retropulsion Devices Market
31. South America Anti-Retropulsion Devices Market
32. Brazil Anti-Retropulsion Devices Market
33. Middle East Anti-Retropulsion Devices Market
34. Africa Anti-Retropulsion Devices Market
36. Anti-Retropulsion Devices Market Competitive Landscape and Company Profiles
37. Anti-Retropulsion Devices Market Other Major and Innovative Companies
40. Anti-Retropulsion Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Anti-Retropulsion Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses anti-retropulsion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for anti-retropulsion devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anti-retropulsion devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Basket Type Anti-Retropulsion Devices; Balloon Type Anti-Retropulsion Devices; Mechanical Retropulsion Devices2) By Application: Ureteroscopy; Lithotripsy
3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Basket Type Anti-Retropulsion Devices: Self-Expanding Basket Devices; Balloon-Expandable Basket Devices; Balloon Type Anti-Retropulsion Devices;2) By Balloon Type Anti-Retropulsion Devices: Single-Lumen Balloon Devices; Multi-Lumen Balloon Devices; Other Anti-Retropulsion Devices;
3) By Mechanical Retropulsion Devices: Mechanical Retropulsion Devices; Stent-Based Anti-Retropulsion Devices.
Companies Mentioned: Johnson & Johnson; Medtronic plc; Boston Scientific Corporation; Cook Medical Incorporated; KARL STORZ SE & Co KG; Coloplast A/S; ROCAMED SAM; Endotherapeutics Pty Ltd; Dornier MedTech GmbH; Accordion Medical LLC; Cogentix Medical Inc.; NeoScope Inc; OTU Medical; Clarion Medical Technologies; Calyxo Inc; EMS Urology; Happiness Works Medical; PENTAX Medical; UROMED Kurt Drews KG; EndoTheia Inc; Maxer Endoscopy GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Anti-Retropulsion Devices market report include:- Johnson & Johnson
- Medtronic plc
- Boston Scientific Corporation
- Cook Medical Incorporated
- KARL STORZ SE & Co KG
- Coloplast A/S
- ROCAMED SAM
- Endotherapeutics Pty Ltd
- Dornier MedTech GmbH
- Accordion Medical LLC
- Cogentix Medical Inc.
- NeoScope Inc
- OTU Medical
- Clarion Medical Technologies
- Calyxo Inc
- EMS Urology
- Happiness Works Medical
- PENTAX Medical
- UROMED Kurt Drews KG
- EndoTheia Inc
- Maxer Endoscopy GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.75 Billion |
| Forecasted Market Value ( USD | $ 3.51 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
